All the mentioned findings point to the important part of CXCR3-expressing CD8+ T cells in progressive damage to targeting tissues of drying in pSS; as well, targeting CXCR3+ CD8+ T cells may be a new strategy for disease immunotherapy. This evidence concerns the gene CXCR3 and peeling skin syndrome.